The chemokine receptor CXCR4 functions as human immunodeficiency virus (HIV)-1 coreceptor and is involved in acquired immunodeficiency virus (AIDS) neuropathogenesis. CXCR4 is expressed by most cell types in the brain, including microglia, astrocytes, and neurons. Studies have shown that the HIV envelope protein gp120 binds to neuronal CXCR4 and activates signal transduction pathways leading to apoptosis. However, the natural CXCR4 ligand (CXCL12) has been referred to induce both neuronal survival and death. Here the authors used flow cytometry to determine whether gp120 and CXCL12 differ in their ability to induce CXCR4 internalization in the human neuroblastoma cells SH-SY5Y, which constitutively express CXCR4. As expected, increasing concentration of CXCL12 reduced surface expression of CXCR4 in a time-and concentration-dependent manner. Conversely, gp120 IIIB (monomeric or oligomeric, in presence or absence of soluble CD4) did not change CXCR4 membrane levels. Similar results were obtained in a murine lymphocyte cell line (300-19) stably expressing human CXCR4. Nevertheless, gp120 IIIB was still able to activate intracellular signaling and proapoptotic pathways, via CXCR4. These results show that gp120 IIIB toxicity and signaling do not require CXCR4 internalization in SH-SY5Y cells, and suggest that the viral protein may alter normal CXCR4 trafficking thus, interfering with activation of prosurvival pathways. Journal of NeuroVirology (2006) 12, 211-218.
Introduction
The chemokine receptor CXCR4 is involved in the neurological complications of acquired immunodeficiency syndrome (AIDS) (Kaul et al, 2001; Address correspondence to Olimpia Meucci, MD, PhD, Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 North 15th Street, NCB Room 8804, Philadelphia, PA 19102, USA. E-mail: olimpia.meucci@drexel.edu
The following reagent was obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: HIV-1 SF2 gp120 from Chiron Corporation. This work was supported by the NIH grants DA15014 and DA19808 to OM. JP was partially supported by an NRSA fellowship (DA-020234).
Received 3 Abbreviations used: HIV, Human Immunodeficiency Virus; AIDS, acquired immune deficiency syndrome; gp120, glycoprotein 120KDa, GPCRs, G protein-coupled receptors; PI3K, phosphoinositide-3 kinase; AKT, serine/threonine kinase AKT/PKB; ERK, extracellular signal-regulated kinase. et al, 2003b) . CXCR4 is the specific receptor for the chemokine CXCL12 (previously known as SDF-1), which orchestrates the development of many areas of the brain as well as other tissues (Lazarini et al, 2003; Tran and Miller, 2003; Zou et al, 1998) . CXCR4 can also bind the human immunodeficiency virus (HIV) envelope protein gp120 that induces apoptotic cell death in primary neurons and cell lines (Bachis and Mocchetti, 2004; Catani et al, 2000; Hesselgesser et al, 1997; Kaul and Lipton, 1999; Mattson et al, 2005; Meucci and Miller, 1996) . Despite a convincing role of gp120 in the apoptosis of neurons, the effects of CXCL12 on neuronal survival remain controversial.
In vivo studies indicate that the CXCR4/CXCL12 pair is crucial to neuronal development and proliferation, and a number of in vitro evidence favors a prosurvival action of this chemokine (Chalasani et al, 2003; Khan et al, 2003; Meucci et al, 1998) . However, studies from other authors suggest that CXCL12 G Bardi et al can also be neurotoxic (Kaul and Lipton, 1999) . A recent report demonstrated that only a cleaved form of the chemokine-produced by the action of matrix metalloproteinases under pathological conditions, namely HIV encephalitis-is responsible for cell death (Zhang et al, 2003a) . Interestingly, cleaved CXCL12 does not bind to CXCR4 as well as the fulllength protein. This is in agreement with our previous studies showing that recombinant CXCL12 promotes neuronal survival and that differences in the intracellular signaling activated by CXCL12 and gp120 exist. Specifically, our data show that, although gp120 is able to stimulate mitogen-activated protein (MAP) kinases, and to induce Ca 2+ rise in neurons, it is unable to activate prosurvival pathways, such as the phosphoinositide-3 kinase/(PI3K)/AKT pathway, which is necessary for chemokine neurotrophic action (Khan et al, 2004; Meucci et al, 1998) . Moreover, gp120 and CXCL12 also differ in their regulation of specific cell cycle proteins involved in neuronal survival, namely p53, Rb, and E2F (Khan et al, 2003 (Khan et al, , 2005 , which are directly and indirectly modulated by AKT. This could depend on differences in the intrinsic efficacies of the two CXCR4 ligands (Khan et al, 2004) and/or the presence of multiple receptor conformations (Baribaud et al, 2001; Zhou et al, 2002) . Furthermore, based on recent evidence suggesting that receptor internalization may regulate G protein-coupled receptor (GPCR)-mediated signaling in various ways (Lefkowitz and Shenoy, 2005) , we hypothesized that gp120 and CXCL12 may also diverge in their ability to induce CXCR4 internalization. Indeed, studies on alpha-thrombin receptor (a member of the GPCR family) have shown that the expression of a dominant negative beta-arrestin 1 (a group of intracellular proteins that promote receptor endocytosis and recycling) inhibits the rapid activation of the PI3K/AKT pathway without affecting the extra cellular signal-regulated kinase (ERK) pathway Lefkowitz and Shenoy, 2005) .
In order to determine whether differences in intracellular signaling and biological outcomes between CXCL12 and gp120 are associated with alterations in receptor trafficking, we studied the effect of the viral protein on CXCR4 internalization in the human neuroblastoma cell line SH-SY5Y by flow cytometry. Though other studies have previously reported the effect of gp120 on CXCR4 internalization, the data are quite controversial (Badr et al, 2005; Bodner et al, 2003; Fernandis et al, 2002 Fernandis et al, , 2003 Tarasova et al, 1998) , and the correlation between internalization, signaling, and toxicity have not been addressed. Furthermore, most of the previous studies were performed on cells transfected with CXCR4, whereas SH-SY5Y cells constitutively express CXCR4. This is a crucial aspect, considering that the signal transduction machinery may be quite different in cells that do not normally express CXCR4. The results reported here show that, despite the effect of the viral protein on cell signaling and survival, treatment of cells with gp120 IIIB (alone or in complex with CD4) did not affect surface expression of CXCR4. These findings suggest that gp120-induced signaling and neurotoxicity do not require receptor internalization.
Results
Several studies have reported the neurotoxic effect of gp120 in vitro and in vivo and the involvement of chemokine receptors in this process (Catani et al, 2000; Hesselgesser et al, 1998; Kaul and Lipton, 1999; Meucci and Miller, 1996; Pandey and Bolsover, 2000; Zheng et al, 1999) . In line with these reports, treatment of SH-SY5Y cells with gp120 IIIB (200 pM) resulted in significant, albeit moderate, cell death (Figure 1) , which was blocked by pretreatment with AMD3100 (100 ng/ml). This result confirms the involvement of CXCR4 in gp120 IIIB -induced death of SH-SY5Y cells.
As the gp120 is expressed on the HIV virus as a trimeric complex, we asked whether gp120-induced toxicity was higher in cultures treated with an oligomeric form of the protein. Furthermore, as binding of HIV to the chemokine receptor is regulated by CD4, we tested the action of gp120 IIIB /CD4 complexes on the neuroblastoma cells. However, comparable levels of cell death were induced by monomeric and oligomeric gp120 IIIB either in the presence or absence of CD4 ( Figure 1B ). Of note, dependence of gp120 IIIB on CD4 has been reported to be a cell type-specific event (Bodner et al, 2003) . Treatment of SH-SY5Y cells with CXCL12 (20 nM) or AMD3100 (100 ng/ml) alone did not affect basal cell survival (P > 0.05 versus control), as expected ( Figure 1B ).
Changes in cell surface expression of CXCR4 induced by gp120 IIIB (or CXCL12) were studied by flow cytometry. SH-SY5Y cells were incubated for 60 min at 37
• C with increasing concentrations of either ligand, ranging from 20 pM to 20 nM ( Figure 2 ). The samples were stained with a phycoerythrin-conjugated mouse monoclonal antibody as described in the methods section, and analyzed by fluorescence-activated cell sorting (FACS). To quantify differences in receptor expression, we measured the mean fluorescence intensity after every treatment and evaluated the percentage of CXCR4 on the cell surface of treated cells in comparison to the untreated cells. As expected, CXCL12 reduced surface expression of CXCR4 in a time-and dosedependent manner, whereas gp120 IIIB (up to 20 nM) did not change CXCR4 level (Figure 2 ). Incubation with 20 nM CXCL12 for 60 min led to a reduction of CXCR4 staining greater than 50% ( Figure 2B ).
To determine whether longer treatments were required to observe receptor internalization by gp120 IIIB , SH-SY5Y cells were incubated with the ligands up to 12 h. In agreement with the previous experiments, gp120 IIIB (200 pM) did not affect • C. Two groups of samples were pretreated for 15 min at 37
• C with 100 ng/ml of AMD3100 and subsequently treated with vehicle or monomeric gp120 IIIB (200 pM) for 24 h at 37
• C. At the end of the treatment, cells were fixed, stained for cleaved caspase 3 (red in A), and counted. The graph shows percentage of dead cells (mean ± SEM) from three independent experiments (B). Six microscopic fields per coverslip were counted and three coverslips per treatment were used for each experiment. ( * * * P < 0.001 gp120s versus control;ˆP < 0.001, gp120 IIIB versus AMD3100 + gp120 IIIB ).
CXCR4 surface expression at any time point observed ( Figure 2C ). Similar results were obtained with a high concentration of gp120 IIIB (20nM, up to 4 h) (data not shown). On the contrary, CXCL12 (20 nM) internalized the receptor reaching the maximal level within the first 2 h. After this time the receptor expression gradually returned towards basal level reaching about 80% at 12 h ( Figure 2C ). This surface expression dynamics likely depends on ligand degradation (which reduces ligand-induced G Bardi et al internalization) and recycling of the receptor (which helps restoring the receptor membrane pool) (Neel et al, 2005) . Similar results were obtained with the oligomericgp120 IIIB , which was unable to induce internalization of the chemokine receptor on SH-SY5Y neuroblastoma cells ( Figure 3A) . Also, binding of gp120 IIIB to equimolar concentrations of human soluble CD4 did not change CXCR4 expression on the surface of treated cells ( Figure 3A) . We then tested a gp120 from a different HIV strain, i.e., the gp120 SF2 . Treatment with 20 nM gp120 SF2 at 37
• C for 60 min ( Figure 3A ) or 4 h (data not shown) also did not alter CXCR4 expression on the surface of SH-SY5Y cells. Finally, to determine whether this phenomenon was limited to neuroblastoma cells, we used a mouse pre-B-cell line stably transfected with human CXCR4 (300-19/CXCR4) ( Figure 3B ). These cells were treated with increasing concentration of gp120 IIIB or CXCL12 for 60 min ( Figure 3B ). Experiments with the oligomeric gp120 IIIB (20 nM) were also performed ( Figure 3C ). Altogether, these studies showed that, though CXCL12 induces a dose-dependent internalization of CXCR4, reaching almost 50% of receptor internalization at a concentration of 2 nM, gp120 IIIB was unable to induce CXCR4 internalization in the mouse pre-B cells. This is shown by the complete overlay of the traces of untreated cells (blue) and cells treated with either monomeric-gp120 IIIB (orange) or oligomeric-gp120 IIIB (green) ( Figure 3C ).
The results of the flow cytometry studies could raise concerns about the ability of gp120 to signal through the chemokine receptor on SH-SY5Y cells. Thus, we tested the ability of the viral protein to activate CXCR4-dependent pathways, such of ERK1/2 phosphorylation, caspase activation or other apoptotic pathways (Garden et al, 2002; Khan et al, 2005; Meucci et al, 1998) . As previously reported in different cells (Khan et al, 2004; Lazarini et al, 2000; Meucci et al, 1998) , CXCL12 and gp120 IIIB are both able to induce phosphorylation of ERK1/2 in SH-SY5Y cells ( Figure 4A) , with peak responses generally observed at 5 min for both ligands (data not shown). This effect was completely blocked by pretreatment of cells with the CXCR4 specific inhibitor AMD3100 (100 ng/ml) (Figure 4) . The HIV protein also stimulated, in an AMD3100-dependent manner, caspase 3 cleavage ( Figure 1A ) and E2F1 activity (Shimizu et al, submitted) . These results demonstrate the presence of a functional chemokine receptor on the surface of SH-SY5Y neuroblastoma cells and show that gp120 IIIB -induced cell death and signaling do not require CXCR4 internalization in the neuroblastoma cells.
Discussion
Chemokine receptors expressed on the cell surface undergo a basal level of internalization and • C without (control) or with 20 nM of the indicated ligands. Bars represent the averages of two to four independent experiments ± SEM. (B) 300-19/CXCR4 cells were incubated for 60 min at 37
• C with increasing concentrations of gp120 IIIB (open triangles) or CXCL12 (red filled triangles). The percentage of receptor expression from two independent experiments as compared to control cells is shown (mean ± SEM) (treatments versus control, * P < 0.05; * * P < 0.01; * * * P < 0.001). (C) Representative traces from a FACS analysis experiment in 300-19/CXCR4 cells (60 min at 37
• C). A total of three independent experiments with both monomeric and oligomeric gp120 IIIB as well as the CXCL12 control were performed; untreated cells (blue trace), 20 nM monomeric-gp120 IIIB (orange trace), 20 nM oligomeric-gp120 IIIB (green trace), 20 nM CXCL12 (red trace). The gray trace represents the antibody isotype control. degradation in absence of specific ligand (Signoret et al, 2000) . A certain amount of receptors on the cell membrane is maintained by new synthesis and recycling mechanisms. Internalization of chemokine The densitometry analysis of the bands (mean ± SEM) of three independent experiments (CXCL12 + AMD versus CXCL12,P * < 0.05; gp120 IIIB + AMD versus gp120 IIIB , * * * P < 0.001).
receptors can be enhanced by ligand binding leading to a clathrin-mediated or lipid raft/caveolaedependent endocytosis (Neel et al, 2005) . This agonist-mediated receptor internalization represents an important physiological feedback mechanism that protects the cell against acute and chronic overstimulation. The signaling through CXCR4 in brainderived cells can result in opposite biological events, such as survival or apoptosis (Chalasani et al, 2003; Kaul and Lipton, 1999; Khan et al, 2004; Meucci et al, 1998) . Activation of these pathways may depend on the nature of the ligand and the subsequent intracellular events (Khan et al, 2005; Zhang et al, 2003a) . The present study suggests that CXCR4 internalization may also contribute to the different effects of CXCR4 on cell survival. The fact that gp120 does not induce CXCR4 internalization emphasizes a potential role of CXCR4 internalization in the activation of prosurvival pathways-although this still remains to be proven. However, previous studies showing that CXCL12, but not gp120, activates the PI3K/AKT pathway (Khan et al, 2004) support this hypothesis. In addition, studies from other investigators indicate that beta-arrestins (which mediate receptor internalization) are instrumental in the coupling of GPCRs and tyrosine kinases receptors to antiapoptotic pathways, including AKT Povsic et al, 2003; Revankar et al, 2004) . Thus, pathways regulated by AKT (such as the Rb/E2F pathway) could be altered as well (Khan et al, 2003) . The inability of gp120 to induce CXCR4 internalization was also reported in a CXCR4-transfected cell line (Wang et al, 1998) . These authors found that a specific anti-CD4 antibody was required for the internalization of the gp120/CXCR4/CD4 complex, and suggest that CXCR4 endocytosis is secondary to CD4-dependent signaling. Indeed, our results in SH-SY5Y cells and those from other investigators in hematopoietic CD34
+ cells demonstrate that soluble CD4 is not sufficient for gp120 to trigger CXCR4 internalization, whereas gp120 causes CXCR4 internalization in CD4+ lymphocytes (Aiuti et al, 1999; Fernandis et al, 2002) . Altogether, these data suggest that gp120-induced CXCR4 endocytosis is strictly dependent on the cellular expression of CD4, at least in certain cells. As neurons do not generally express the CD4 molecule, it is possible that gp120 does not cause CXCR4 internalization in neurons in vivo. This hypothesis is also supported by our previous studies (Khan et al, 2004) showing that pretreatment of CD4 − /CXCR4 + cells with gp120 IIIB did not abolish calcium responses stimulated by the physiological CXCR4 agonist (CXCL12), suggesting that the viral protein is unable to induce proper CXCR4 down-regulation despite that it activates several intracellular responses (Meucci et al, 1998 , and this study). However, a recent confocal microscopy study reported a time-dependent internalization of recombinant gp120 in cerebellar granule neurons (Bachis et al, 2003) . The authors find that internalization of biotin-conjugated gp120 is blocked by brain-derived neurotrophic factor, which also prevents gp120 neurotoxicity and reduces CXCR4 expression, i.e., CXCR4 total protein levels. The effect of gp120 on CXCR4 internalization/surface expression, however, is not reported in their study. Moreover, gp120 internalization was not observed in glial cells (Bachis et al, 2003) , which also express CXCR4, thus questioning whether this is a CXCR4-dependent event (Lazarini et al, 2003) . Thus, the apparent discrepancy with our findings could be due to various scenarios, including differences in the cell types and experimental approaches, the reported binding of gp120 to other molecules expressed on the neuronal surface, such as glycosphingolipids Long et al, 1994) , and/or the expression of unknown CD4-like molecules in G Bardi et al granule neurons. Alternatively, the HIV envelope protein could enter the cell via ligand-independent chemokine receptor internalization (Neel et al, 2005; Signoret et al, 2000) , which would be consistent with the kinetics of gp120 accumulation in cerebellar granule neurons (Bachis et al, 2003) . On the other hand, the dynamics of CXCR4 expression on the membrane of SH-SY5Y cells treated with CXCL12 (Figure 2 ) is a typical example of ligand-induced receptor endocytosis, a common and reversible mechanism of desensitization of chemokine receptor and GPCRs in general (Ferguson, 2001; Neel et al, 2005) .
In conclusion, our findings show that gp120-induced signaling and toxicity is independent of CXCR4 internalization. Thus, gp120 and CXCL12 differ in their interaction with CXCR4 at multiple levels, which may also include receptor trafficking. However, it remains to be established whether this phenomenon is responsible for the altered coupling of CXCR4 to survival pathways upon stimulation by the HIV envelope protein.
Materials and methods

Cells cultures
SH-SY5Y human neuroblastoma cells were obtained from ATCC and cultured in 45% minimum essential medium, 45% Ham's F-12 medium, 10% fetal bovine serum (FBS) containing 50 μg/ml gentamycin. Medium was replaced every 3 days. Mouse pre-B 300-19 cells stably transfected with human CXCR4 were a kind gift from Dr. Bernhard Moser (Institute of Cell Biology, University of Bern, Switzerland). These cells were cultured in RPMI 1640 supplemented with 10% FBS, 1% nonessential amino acids, 1mM sodium pyruvate, 0.05 mM β-mercaptoethanol, 50 U/ml penicillin, 50 mg/ml streptomycin, 2 mM glutamine, and 1.5 μg/mL puromycin.
Flow cytometry SH-SY5Y or 300-19/CXCR4 cells were treated with CXCL12 or gp120s as indicated in the appropriate figures for different times at 37
• C. After treatments, cells were washed and resuspended in cold Ca 2+ -free phosphate-buffered saline (PBS), and then incubated in PBS supplemented with 10% horse serum (30 min on ice). Cells were then resuspended in FACS buffer (1% bovine serum albumin (BSA)/PBS) and incubated (30 min on ice in the dark) with 12.5 μg/ml (5 μg/ml for 300-19/CXCR4 cells) phycoerythrin (PE)-conjugated antibodies (FAB173P; R&D System). We used a mouse monoclonal anti-human CXCR4-PE and a mouse IgG2B-PE as the isotype control. After incubation, cells were washed and fixed with 1% paraformaldehyde in FACS buffer. Samples acquisition was performed with a FACS Calibur (BD).
Survival
Cell death was evaluated 24 h after treatment. Hoechst 33342 (2 μg/ml) was used to evaluate differences between normal and apoptotic nuclei (Meucci et al, 1998) . Additionally, cleaved caspase 3 staining with an antibody that specifically recognizes cleaved/active caspase 3 (80 ng/ml; Cell Signaling) was also used to identify apoptotic cells as described previously (Khan et al, 2005) . Six microscopic fields per coverslip were counted and three coverslips/treatment were used for each experiment. Analysis of the staining has been performed using Metamorph (Universal Imaging) software.
Western Blots
Following drug treatment, cells were washed with ice-cold PBS, scraped with lysis buffer (150 mM NaCl, 50 mM Tris, 0.5% Na deoxycholate, 0.1% sodium dodecyl sulfate [SDS] , 10 mM Na 4 P 2 O 7 , 5 mM EDTA, 1% Triton X, 5 μg each of aprotinin, leupeptin, and pepstatin/1 mM 4-(2 aminoethyl)benzeresulfonyl fluoride HCE (AEBSF)/1 mM vanadate], and incubated for 30 min on a rotor at 4
• C. After centrifugation at 20,800 × g for 10 min, the protein concentration of the supernatants was determined by the bicinchoninic acid protein assay (PIERCE). Equal amout of protein (40 μg) were loaded in each lane. Proteins were resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to PVDF membranes for immunoblotting. After blotting for pERK (11.25 ng/ml), membranes were stripped and reprobed for total ERK (1.25 ng/ml). Both antibodies are from Cell Signaling Technology. Horseradish peroxidase (HRP)-conjugated Protein A (1:20000; Sigma) was used to resolve the bands. An image acquisition and analysis system, from Alpha Innotech (FluorChem 8900) was used for detection of chemiluminescent bands and densitometry analysis. Intensity levels from total ERK bands were used to normalize phosphoprotein signals and compensate for possible variations in protein loading. Data are reported as mean ± SEM.
Reagents
Unless otherwise specified, tissue culture media are from Gibco-Invitrogen and other general reagents are from Sigma. CXCL12 was purchased from PeproTech (NJ). Recombinant HIV-1 gp120 IIIB (both monomeric and oligomeric) was from ImmunoDiagnostics. Stock solutions of gp120s and CXCL12 were prepared and stored as previously described (Meucci et al, 1998) . AMD3100 was obtained from Sigma and dissolved in sterile water before further dilution in culture medium. gp120-sCD4 binding was achieved after 30 min incubation at 37
• C of equimolar amount of the two reagents as previously described by (Bodner et al, 2003) . Recombinant soluble CD4 was from Intracel Corporation.
